DK3068428T3 - Annexin-ii-variant-sammensætninger og fremgangsmåder - Google Patents
Annexin-ii-variant-sammensætninger og fremgangsmåder Download PDFInfo
- Publication number
- DK3068428T3 DK3068428T3 DK14812331.8T DK14812331T DK3068428T3 DK 3068428 T3 DK3068428 T3 DK 3068428T3 DK 14812331 T DK14812331 T DK 14812331T DK 3068428 T3 DK3068428 T3 DK 3068428T3
- Authority
- DK
- Denmark
- Prior art keywords
- annexin
- methods
- variant compositions
- variant
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46449—Melanoma antigens
- A61K39/464492—Glycoprotein 100 [Gp100]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361903628P | 2013-11-13 | 2013-11-13 | |
PCT/US2014/065390 WO2015073632A1 (en) | 2013-11-13 | 2014-11-13 | Annexin ii variant compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3068428T3 true DK3068428T3 (da) | 2022-10-17 |
Family
ID=52101577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14812331.8T DK3068428T3 (da) | 2013-11-13 | 2014-11-13 | Annexin-ii-variant-sammensætninger og fremgangsmåder |
Country Status (9)
Country | Link |
---|---|
US (1) | US10206986B2 (da) |
EP (1) | EP3068428B1 (da) |
AU (1) | AU2014348645B2 (da) |
CA (1) | CA2930567C (da) |
DK (1) | DK3068428T3 (da) |
ES (1) | ES2928331T3 (da) |
HU (1) | HUE060293T2 (da) |
PL (1) | PL3068428T3 (da) |
WO (1) | WO2015073632A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016146143A1 (en) * | 2015-03-16 | 2016-09-22 | Amal Therapeutics Sa | Cell penetrating peptides and complexes comprising the same |
HRP20221372T1 (hr) * | 2016-06-10 | 2023-01-06 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Domena jezgre aneksina i njihova upotreba u isporuci antigena i cijepljenju |
KR20190057345A (ko) * | 2016-09-21 | 2019-05-28 | 아말 테라퓨틱스 에스에이 | 암 치료를 위한, 세포 투과 펩타이드, 멀티 에피토프 및 tlr 펩타이드 작용제를 포함하는 융합체 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7262167B2 (en) | 1995-11-06 | 2007-08-28 | Exibona Ltd. | Drug, in particular for modulating the immunological response for the control of viruses, tumors, bacteria and parasites |
US6645465B2 (en) | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
JP2004507482A (ja) * | 2000-09-01 | 2004-03-11 | フィラデルフィア・ヘルス・アンド・エデュケーション・コーポレーション | 血管新生を阻害するための方法および組成物 |
DE10225144A1 (de) | 2002-05-29 | 2003-12-18 | Immatics Biotechnologies Gmbh | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
US7695725B2 (en) | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
EP2373338B1 (en) | 2008-12-03 | 2017-02-15 | The Johns Hopkins University | Annexina2 as immunological target |
KR101121198B1 (ko) * | 2009-05-20 | 2012-03-23 | (주)노바셀테크놀로지 | 태반에서 추출된 펩타이드 혼합물, 그의 제조 방법 및 용도 |
US9555074B2 (en) | 2010-10-08 | 2017-01-31 | Regents Of The University Of Minnesota | Annexin II compositions |
-
2014
- 2014-11-13 AU AU2014348645A patent/AU2014348645B2/en active Active
- 2014-11-13 ES ES14812331T patent/ES2928331T3/es active Active
- 2014-11-13 DK DK14812331.8T patent/DK3068428T3/da active
- 2014-11-13 EP EP14812331.8A patent/EP3068428B1/en active Active
- 2014-11-13 US US15/036,115 patent/US10206986B2/en active Active
- 2014-11-13 PL PL14812331.8T patent/PL3068428T3/pl unknown
- 2014-11-13 CA CA2930567A patent/CA2930567C/en active Active
- 2014-11-13 HU HUE14812331A patent/HUE060293T2/hu unknown
- 2014-11-13 WO PCT/US2014/065390 patent/WO2015073632A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2930567A1 (en) | 2015-05-21 |
CA2930567C (en) | 2023-09-26 |
PL3068428T3 (pl) | 2023-03-13 |
HUE060293T2 (hu) | 2023-02-28 |
US20160279212A1 (en) | 2016-09-29 |
WO2015073632A1 (en) | 2015-05-21 |
AU2014348645B2 (en) | 2019-01-24 |
EP3068428B1 (en) | 2022-08-17 |
EP3068428A1 (en) | 2016-09-21 |
ES2928331T3 (es) | 2022-11-17 |
AU2014348645A1 (en) | 2016-06-02 |
US10206986B2 (en) | 2019-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3043784T3 (da) | Arylethere og anvendelser deraf | |
DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
BR112015028459A2 (pt) | composições e comestíveis | |
DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
DK3342773T3 (da) | Syk-hæmmere | |
DK3613453T3 (da) | Fordamper | |
DK3381917T3 (da) | Imidazopyridinforbindelser og anvendelser deraf | |
DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
DK3065771T3 (da) | Fremgangsmåder og sammensætninger til vedvarende immunterapi | |
DK2986722T3 (da) | Manipulerede phenylalaninammoniak-lyasepolypeptider | |
DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
DK3060200T3 (da) | Tyrosinderivater og sammensætninger dermed | |
DK3077047T3 (da) | Aramcholsalte | |
DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
DK3027750T3 (da) | Biokatalytisk sammensætning | |
DK3060460T3 (da) | Saddel | |
DK3027598T3 (da) | Oxoquinazolinyl-butanamidderivater | |
DK3058936T3 (da) | Peptidsammensætning og anvendelser deraf | |
DK2956698T5 (da) | Bindestrimler | |
DK3052081T3 (da) | Pastil | |
DK2946640T3 (da) | Langmuir-probe | |
DK2849798T3 (da) | Oligonukleotid-chelatkompleks-polypeptidsammensætninger og fremgangsmåder |